Efficacy of dasatinib in conjunction with alpha-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia

Leukemia. 2009 Sep;23(9):1687-8. doi: 10.1038/leu.2009.96. Epub 2009 May 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Benzamides
  • Dasatinib
  • Drug Resistance, Neoplasm
  • Female
  • Fusion Proteins, bcr-abl / genetics
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Imatinib Mesylate
  • Interferon-alpha / administration & dosage*
  • Middle Aged
  • Piperazines / therapeutic use*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Pyrimidines / administration & dosage*
  • Pyrimidines / therapeutic use*
  • Thiazoles / administration & dosage*
  • Transplantation, Autologous

Substances

  • Benzamides
  • Interferon-alpha
  • Piperazines
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Fusion Proteins, bcr-abl
  • Dasatinib